查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球膽道支架市場-2022-2029
市場調查報告書
商品編碼
1140757

全球膽道支架市場-2022-2029

Global Biliary Stents Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 200 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場概覽

預計膽道支架的市場規模在預測期內（2022-2029 年）將以 4.4% 的複合年增長率增長。

膽道支架是一種沒有塗層或覆蓋物的小網狀管。膽道支架用於治療膽管中存在的阻塞。支架通常插入肝臟以治療肝阻塞和阻塞性肝病，例如膽囊炎、黃疸、肝膽疾病和膽管炎。

市場動態

主要驅動因素是膽道疾病患病率的增加、對微創技術的需求增加、技術進步、老年人口的增長、公眾意識的提高以及對生物可吸收支架的需求增加。

新興市場的發展正在推動市場增長。

膽道支架的不斷進步和開發正在推動全球膽道支架市場的增長。例如，膽道支架技術自問世以來已經走過了漫長的道路。在使用的材料以及設計和部署策略方面取得了重大進展。選擇範圍已從塑料和金屬支架擴展到更廣泛的材料和製造技術，為臨床醫生提供了多種選擇，包括自膨脹金屬支架和生物可吸收支架。生物可吸收膽管支架仍處於臨床應用的早期階段。此外，正在發生的市場發展正在推動全球市場的增長。例如，21 年 7 月 9 日，QualiMed 的 UNITY-B 經皮球囊可擴張生物降解膽道支架 (BEBS) 獲得了 CE 標誌批准，這是一種用於膽道應用的專用經皮可生物降解金屬合金支架植入物。

術後並發症正在減緩膽道支架市場的增長。

但是，預計政府對術後並發症和批准的嚴格規定將抑制市場增長。與膽道支架相關的術後並發症可能會阻礙市場。例如，根據歐洲胃腸病學內窺鏡學會的說法，並發症包括膽道感染、胰腺炎、出血、穿孔、支架過早移位和腎功能衰竭。

行業分析。

膽道支架市場報告根據波特五力、研發、流行病學、監管、價格分析等各種行業因素對市場進行了深入分析。

細分分析

金屬膽管支架預計將在預測期內（2022-2029 年）主導市場。

金屬膽道支架將在 2021 年主導全球市場，由於金屬支架在膽道疾病治療中的使用越來越多，預計在預測期內（2022-2029 年）將出現顯著增長。與塑料支架相比，金屬支架可以提供更長的支架通暢性。金屬支架的可擴展性基於其可擴展性，這反過來可能由於更好的好處而導致更好的客戶採用。金屬膽管支架技術創新的興起將在預測期內推動金屬膽管支架市場的增長。例如，根據 NIH 的說法，如果患者的預期壽命超過四到六個月，金屬支架比塑料膽管支架更具成本效益。因此，在治療惡性膽道梗阻時，通常首選裸金屬支架而不是塑料支架。

區域分析

預計北美將佔據大部分市場份額。

北美胰腺疾病患病率的上升正在推動北美地區在預測期內（2022-2029 年）佔據市場主導地位。例如，根據美國國立衛生研究院的數據，美國每 10 萬人中約有 42 至 73 人患有慢性胰腺炎。它被認為是與胰腺功能不全相關的最常見的胰腺疾病。此外，根據美國癌症協會的數據，約有 62,210 人（32,970 名男性和 29,240 名女性）將被診斷出患有胰腺癌，約有 49,830 人（25,970 名男性和 23,860 名女性）死於胰腺癌。此外，北美擁有最先進、最強大的醫療保健基礎設施和出色的醫療報銷政策，使北美在全球膽管支架市場佔據主導地位。

競爭格局

全球膽道支架市場的主要參與者有Boston Scientific Corporation、Brainlab、Q3 Medical Devices Limited、Medtronic、Abbott、Allium Medical Solutions、Aohua Endoscopy Co, Ltd、Changzhou Health Microport Medical Devices、 W. L. Gore &Associates、Inc.，和Cook Medical。主要參與者採取了各種策略，如產品發布、併購、合作夥伴和聯盟，為全球膽管支架市場的增長做出貢獻。例如，2022 年 8 月 30 日，Medtronic收購了 Affera。

Medtronic

概覽

Medtronic PLC 是一家總部位於愛爾蘭的美國醫療設備製造商。美敦力公司成立於 1949 年，總部位於美國明尼蘇達州明尼阿波利斯市。美敦力經營四項業務：微創治療組、糖尿病組、恢復性治療組和心血管組。

產品組合

美敦力提供一系列膽道支架，包括 EverFlex、Protege 和 Visi-Pro。

這份研究報告將提供對大約 40 多個市場數據表、45 多個圖表和 200 頁（大約）的訪問。

內容

  • 調查方法
  • 調查目的和範圍

第 2 章市場定義和概述

第 3 章執行摘要

第 4 章市場動態

  • 市場影響因素
    • 促進因素
      • 調查與研發
      • 市場策略
    • 抑制因素
      • 術後並發症
      • 嚴格監管
    • 商機
    • 影響分析

第 5 章行業分析

  • 波特五力分析
  • 流行病學分析
  • 研發
  • 管道分析
  • 供應鏈分析
  • 監管分析

第 6 章 COVID-19 分析

  • COVID-19 的市場分析
    • COVID-19 之前的市場情景
    • COVID-19 的當前市場情景
    • COVID-19 後或未來情景
  • COVID-19 期間的價格動態
  • 供需範圍
  • 大流行期間與市場相關的政府舉措
  • 製造商的戰略舉措
  • 總結

第 7 章按應用程序

  • 膽石症
  • 膽漏
  • 腫瘤
  • 其他

第 8 章按類型

  • 金屬支架
  • 塑料支架

第 9 章最終用戶

  • 醫院
  • 門診手術中心
  • 其他

第 10 章按地區劃分

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 意大利
    • 西班牙
    • 其他歐洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 其他亞太地區
  • 中東和非洲

第 11 章競爭格局

  • 主要發展和戰略
  • 公司份額分析
  • 產品基準

第 12 章公司簡介

  • Medtronic
    • 公司概況
    • 產品組合和描述
    • 主要亮點
    • 財務摘要
  • Boston Scientific Corporation
  • Brainlab
  • Q3 Medical Devices Limited
  • Abbott
  • Allium Medical Solutions
  • Aohua Endoscopy Co., Ltd
  • Changzhou Health Microport Medical Devices
  • W. L. Gore & Associates, Inc.
  • Cook Medical

第 13 章 DataM

簡介目錄
Product Code: DMMD2180

Market Overview

Biliary Stents Market size was valued at US$ XX million in 2021 and is estimated to reach US$ XX million by 2029, growing at a CAGR of 4.4% during the forecast period (2022-2029).

Biliary stents are small mesh-like tubes with no coating or covering. Biliary stents are used to treat obstructions present in the bile duct. Stents are usually inserted into the liver to treat hepatic blockage and obstructive hepatic diseases, like cholecystitis, jaundice, hepato-biliary diseases, and cholangitis.

Market Dynamics

The major driving forces are the increasing prevalence of biliary diseases, increase in demand for minimally invasive techniques, technological advancements, the rise in geriatric populations, an increase in awareness among the population and rising demand for bioresorbable stents.

The advancements and developments are pushing the market's growth.

The rising advancements and developments in biliary stents drive the global biliary stent market growth. For instance, biliary stent technology has come a long way since its inception. There have been significant advancements in the materials used and design and deployment strategies. Options have expanded from plastic and metallic stents to a wider variety of materials and manufacturing technologies to offer several options to clinicians, including self-expandable metallic stents and bioresorbable stents. Bioresorbable biliary stents are still in the early stages of clinical adoption. Furthermore, the market developments happening are fueling the global market growth. For instance, on 09.07.21, QualiMed received CE mark approval for a dedicated percutaneous biodegradable metal alloy-based stent implant for biliary applications, the UNITY-B Percutaneous Balloon Expandable Biodegradable Biliary Stent (BEBS).

The postoperative complications are slowing the biliary stents market growth.

However, postoperative complications and stringent government regulations for approval are expected to restrain the market growth. The postoperative complications related to biliary stents are likely to hamper the market. For instance, according to the European Society of Gastrointestinal endoscopy, some complications include biliary infection, pancreatitis, bleeding, perforation, early stent migration, and renal failure.

Industry Analysis.

The Biliary Stents market report will provide an in-depth analysis of the market based on various industry factors such as porter`s five forces, research and developments, epidemiology, regulatory, pricing analysis, Etc.

Segment Analysis

The metal biliary stents are estimated to oppress the market during the forecast period (2022-2029).

Metal biliary stents dominated the global market in 2021 and are expected to have significant growth over the forecast period (2022-2029), owing to the increasing use of metal stents for treating biliary diseases. Metal stent gives longer stent patency as compared to plastic stents. Metal stents are available based on their expansion capacity, which may further lead to better customer adoption due to better benefits. The growing innovations in metal biliary stents will drive the metal biliary stents market growth in the forecast period. For instance, according to NIH, Metal stents are more cost-effective than plastic biliary stents if the patient's remaining life expectancy is longer than 4-6 months. Therefore, uncovered metal stents are generally preferred over plastic ones for managing malignant biliary obstruction.

Geographical Analysis

North America is predicted to hold most of the market share.

The growing prevalence of pancreatic diseases in North America pushes the North American region to command the market during the forecast period (2022-2029). For instance, according to the National Institute of Health, chronic pancreatitis occurs in about 42 to 73 per 100,000 of the population in the United States. It is considered the most common pancreatic disorder associated with pancreatic insufficiency. Moreover, according to the American Cancer Society, about 62,210 people (32,970 men and 29,240 women) will be diagnosed with pancreatic cancer, and about 49,830 people (25,970 men and 23,860 women) will die of pancreatic cancer. In addition, North America has the most advanced and robust healthcare infrastructure and better healthcare cost reimbursement policies, contributing to the dominance of North America over the global biliary stents market.

Competitive Landscape

The major global biliary stents market players are Boston Scientific Corporation, Brainlab, Q3 Medical Devices Limited, Medtronic, Abbott, Allium Medical Solutions, Aohua Endoscopy Co., Ltd, Changzhou Health Microport Medical Devices, W. L. Gore & Associates, Inc., and Cook Medical. The key players are adopting various strategies such as product launches, mergers & acquisitions, partnerships, and collaborations, contributing to the growth of the biliary stents market globally. For instance, on AUG 30, 2022, Medtronic acquired Affera.

Medtronic, Plc

Overview

Medtronic plc is Ireland based American medical device company. Medtronic was founded in 1949 and is headquartered in Minneapolis, Minnesota, United States. Medtronics deals with four different businesses: the Minimally Invasive Therapies Group, the Diabetes Group, the Restorative Therapies Group, and the Cardiac and Vascular Group.

Product Portfolio

Medtronic plc `s product portfolio for Biliary Stents has EverFlex, Protege, Visi-Pro etc.

The biliary stents market report would provide access to approximately 40+ market data tables, 45+ figures, and in the range of 200 (approximate) pages.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Research and Development
      • 4.1.1.2. Market Strategies
    • 4.1.2. Restraints
      • 4.1.2.1. Postoperative Complications
      • 4.1.2.2. Stringent Regulatory Bodies
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Epidemiological Analysis
  • 5.3. Research and Developments
  • 5.4. Pipeline Analysis
  • 5.5. Supply Chain Analysis
  • 5.6. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturer's Strategic Initiatives
  • 6.6. Conclusion

7. By Application

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application Segment
    • 7.1.2. Market Attractiveness Index, By Application Segment
  • 7.2. Gall Stones
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3. Biliary Leaks
  • 7.4. Tumor
  • 7.5. Others

8. By Type

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channels Segment.
    • 8.1.2. Market Attractiveness Index, By Distribution Channels Segment
  • 8.2. Metal Stents
    • 8.3.1. Introduction
    • 8.3.2. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.4. Plastic Stents

9. By End-User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User Segment
    • 9.1.2. Market Attractiveness Index, By End-User Segment
  • 9.2. Hospitals
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 9.3. Ambulatory Surgical Centers
  • 9.4. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 10.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. The U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 10.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. The U.K.
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Spain
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

  • 11.1. Key Developments and Strategies
  • 11.2. Company Share Analysis
  • 11.3. Product Benchmarking

12. Company Profiles

  • 12.1. Medtronic
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Key Highlights
    • 12.1.4. Financial Overview
  • 12.2. Boston Scientific Corporation
  • 12.3. Brainlab
  • 12.4. Q3 Medical Devices Limited
  • 12.5. Abbott
  • 12.6. Allium Medical Solutions
  • 12.7. Aohua Endoscopy Co., Ltd
  • 12.8. Changzhou Health Microport Medical Devices
  • 12.9. W. L. Gore & Associates, Inc.
  • 12.10. Cook Medical

LIST NOT EXHAUSTIVE

13. DataM

  • 13.1. Appendix
  • 13.2. About Us and Services
  • 13.3. Contact